company background image
ALEM

Euromedis Groupe ENXTPA:ALEMG Stock Report

Last Price

€6.11

Market Cap

€18.3m

7D

-1.0%

1Y

-64.9%

Updated

21 May, 2022

Data

Company Financials +
ALEMG fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance1/6
Financial Health5/6
Dividends0/6

ALEMG Stock Overview

Euromedis Groupe designs, manufactures, and distributes medical equipment under the Euromedis brand for healthcare professionals, local communities, and individuals in France.

Euromedis Groupe Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Euromedis Groupe
Historical stock prices
Current Share Price€6.11
52 Week High€17.76
52 Week Low€4.85
Beta-0.71
1 Month Change-27.95%
3 Month Change-23.34%
1 Year Change-64.89%
3 Year Change-8.12%
5 Year Change-22.36%
Change since IPO19.80%

Recent News & Updates

Oct 03
Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Jun 12
Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Euromedis Groupe ( EPA:ALEMG ) just reported some strong earnings, and the market rewarded them with a positive share...

Shareholder Returns

ALEMGFR Medical EquipmentFR Market
7D-1.0%2.8%-1.3%
1Y-64.9%-5.9%-5.4%

Return vs Industry: ALEMG underperformed the French Medical Equipment industry which returned -5.9% over the past year.

Return vs Market: ALEMG underperformed the French Market which returned -5.4% over the past year.

Price Volatility

Is ALEMG's price volatile compared to industry and market?
ALEMG volatility
ALEMG Average Weekly Movement12.0%
Medical Equipment Industry Average Movement7.0%
Market Average Movement6.1%
10% most volatile stocks in FR Market10.4%
10% least volatile stocks in FR Market3.6%

Stable Share Price: ALEMG is more volatile than 90% of French stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: ALEMG's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
1985188Mathieu Roturierhttps://www.euromedis.fr

Euromedis Groupe designs, manufactures, and distributes medical equipment under the Euromedis brand for healthcare professionals, local communities, and individuals in France. It offers sterile or non-sterile medical gloves, dressings and compresses, medical sets, parenteral approach, needles, syringes, infusers, catheters, etc.; and the surgical range with wound drainage products, probes, and a draping range for operating theaters, as well as surgical gloves and protective covers. The company also provides oxygen therapy; incontinence and various hygiene-related products; a range of diagnostics; and a range of home care products.

Euromedis Groupe Fundamentals Summary

How do Euromedis Groupe's earnings and revenue compare to its market cap?
ALEMG fundamental statistics
Market Cap€18.27m
Earnings (TTM)€2.26m
Revenue (TTM)€111.90m

8.1x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ALEMG income statement (TTM)
Revenue€111.90m
Cost of Revenue€78.41m
Gross Profit€33.49m
Other Expenses€31.23m
Earnings€2.26m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.75
Gross Margin29.93%
Net Profit Margin2.02%
Debt/Equity Ratio37.0%

How did ALEMG perform over the long term?

See historical performance and comparison

Valuation

Is Euromedis Groupe undervalued compared to its fair value and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: ALEMG (€6.11) is trading below our estimate of fair value (€228.79)

Significantly Below Fair Value: ALEMG is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ALEMG is good value based on its PE Ratio (8.1x) compared to the French Medical Equipment industry average (13.6x).

PE vs Market: ALEMG is good value based on its PE Ratio (8.1x) compared to the French market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: ALEMG is good value based on its PEG Ratio (0.5x)


Price to Book Ratio

PB vs Industry: ALEMG is good value based on its PB Ratio (0.4x) compared to the FR Medical Equipment industry average (2.2x).


Future Growth

How is Euromedis Groupe forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALEMG's forecast earnings growth (17.6% per year) is above the savings rate (0.3%).

Earnings vs Market: ALEMG's earnings (17.6% per year) are forecast to grow faster than the French market (12% per year).

High Growth Earnings: ALEMG's earnings are forecast to grow, but not significantly.

Revenue vs Market: ALEMG's revenue is expected to decline over the next 3 years (-15.1% per year).

High Growth Revenue: ALEMG's revenue is forecast to decline over the next 3 years (-15.1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ALEMG's Return on Equity is forecast to be low in 3 years time (6.1%).


Past Performance

How has Euromedis Groupe performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


47.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ALEMG has a large one-off loss of €1.4M impacting its December 31 2021 financial results.

Growing Profit Margin: ALEMG's current net profit margins (2%) are lower than last year (11.7%).


Past Earnings Growth Analysis

Earnings Trend: ALEMG's earnings have grown significantly by 47.9% per year over the past 5 years.

Accelerating Growth: ALEMG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ALEMG had negative earnings growth (-90%) over the past year, making it difficult to compare to the Medical Equipment industry average (22.5%).


Return on Equity

High ROE: ALEMG's Return on Equity (5.6%) is considered low.


Financial Health

How is Euromedis Groupe's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: ALEMG's short term assets (€64.4M) exceed its short term liabilities (€13.2M).

Long Term Liabilities: ALEMG's short term assets (€64.4M) exceed its long term liabilities (€18.3M).


Debt to Equity History and Analysis

Debt Level: ALEMG has more cash than its total debt.

Reducing Debt: ALEMG's debt to equity ratio has increased from 27.3% to 37% over the past 5 years.

Debt Coverage: ALEMG's debt is well covered by operating cash flow (126.1%).

Interest Coverage: ALEMG's interest payments on its debt are well covered by EBIT (12.6x coverage).


Balance Sheet


Dividend

What is Euromedis Groupe current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ALEMG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ALEMG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ALEMG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALEMG's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: ALEMG is not paying a notable dividend for the French market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ALEMG has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

€290k

CEO Compensation


CEO

Mathieu Roturier

no data

Tenure

€289,518

Compensation

Mr. Mathieu Roturier serves as the Chief Executive Officer at Sa Laboratoires Euromedis. Mr. Roturier serves as a Manager at Sarl Laboratoires Euromedis Italie. He serves as the Chairman of the Board of Di...


CEO Compensation Analysis

Compensation vs Market: Mathieu's total compensation ($USD305.43K) is about average for companies of similar size in the French market ($USD284.13K).

Compensation vs Earnings: Mathieu's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.8%.


Top Shareholders

Company Information

Euromedis Groupe's employee growth, exchange listings and data sources


Key Information

  • Name: Euromedis Groupe
  • Ticker: ALEMG
  • Exchange: ENXTPA
  • Founded: 1985
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: €18.269m
  • Shares outstanding: 2.99m
  • Website: https://www.euromedis.fr

Number of Employees


Location

  • Euromedis Groupe
  • Zi De La Tuilerie
  • Neuilly Sous Clermont
  • Mouy
  • Picardy
  • 60290
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/21 00:00
End of Day Share Price2022/05/20 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.